Sturge Simon has filed 3 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 6682 shares of MoonLake Immunotherapeutics ($MLTX) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | MoonLake Immunotherapeutics | $MLTX | Sturge Simon | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| Oct. 4, 2024 | MoonLake Immunotherapeutics | $MLTX | Sturge Simon | Director | S | Class A ordinary shares, par value $0.0001 per share | 171000 | $53.72 | 171,980.0000 | 62,896,782 | 49.86% | 0.27% |
| June 6, 2024 | MoonLake Immunotherapeutics | $MLTX | Sturge Simon | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |